alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Ancillary Clinical Studies Review.                    

*Date:*                         June 10, 2010.                    

*Time:*                         2 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817. (Virtual Meeting).                    

*Contact Person:*                         Charles H Washabaugh, Scientific Review Officer, Scientific Review Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 Democracy Blvd., Suite 800, Bethesda, MD 20817, 301-594-4952,                         *washabac@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)

Dated: May 5, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-11363 Filed 5-11-10; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 11.0

COMPUTATION OF PER SHARE EARNINGS



|                                     |  | Six Months Ended June 30, |           | Three Months Ended June 30,
|------------------------------------ |  | ------------------------- | --------- | ---------------------------
|                                     |  | 2003                      |           | 2002                       
|Net Income                           |  | $                         | 1,149,158 |                            
|                                     |  |                           |           |                            
|Average Shares Outstanding           |  |                           | 1,805,671 |                            
|                                     |  |                           |           |                            
|Basic Earnings Per Share             |  | $                         | .64       |                            
|                                     |  |                           |           |                            
|Net Income                           |  | $                         | 1,149,158 |                            
|                                     |  |                           |           |                            
|Average Shares Outstanding           |  |                           | 1,805,671 |                            
|Net Effect of Dilutive Stock Options |  |                           | 89,539    |                            
|                                     |  |                           |           |                            
|Adjusted Shares Outstanding          |  |                           | 1,895,210 |                            
|                                     |  |                           |           |                            
|Diluted Earnings Per Share           |  | $                         | .61       |                            
|                                     |  |                           |           |                            



23
<PAGE>



                                                                    EXHIBIT 23.1


                               CONSENT OF KPMG LLP


The Stockholders and Board of Directors
Whittman-Hart, Inc.:

      We consent to incorporation by reference in the registration statements on
Forms S-3 (No. 333-60113), S-4 (No. 333-18059) and S-8 (No. 333-03523) of
Whittman-Hart, Inc. of our reports dated January 14, 1999, relating to the
consolidated balance sheets of Whittman-Hart, Inc. and subsidiaries as of
December 31, 1998 and 1997, and the related consolidated statements of earnings,
stockholders' equity and comprehensive income, and cash flows for each of the
years in the three-year period ended December 31, 1998, and the related
financial statement schedule of valuation and qualifying accounts, which reports
appear in the December 31, 1998 Annual Report on Form 10-K of Whittman-Hart,
Inc. These consolidated financial statements and financial statement schedule
and our reports thereon are included herein.



KPMG  LLP
/s/ KPMG LLP
Chicago, Illinois
March 24, 1999
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
FINANCIAL  STATEMENTS OF METROPOLITAN HEALTH NETWORKS,  INC. FOR THE FISCAL YEAR
ENDED JUNE 30,  1997,  AND IS  QUALIFIED  IN ITS  ENTIRETY BY  REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1

        
<S>                             <C>

<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               JUN-30-1997
<CASH>                                       1,667,887
<SECURITIES>                                   183,276
<RECEIVABLES>                                6,865,166
<ALLOWANCES>                                 3,608,743
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,257,504
<PP&E>                                       4,909,081
<DEPRECIATION>                                 609,265
<TOTAL-ASSETS>                              13,230,528 
<CURRENT-LIABILITIES>                        3,086,617
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0 
<COMMON>                                         5,211 
<OTHER-SE>                                   6,968,509
<TOTAL-LIABILITY-AND-EQUITY>                13,230,528 
<SALES>                                      7,512,185
<TOTAL-REVENUES>                             7,512,185
<CGS>                                                0
<TOTAL-COSTS>                                9,008,511
<OTHER-EXPENSES>                               (76,324)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             511,617
<INCOME-PRETAX>                             (1,931,619) 
<INCOME-TAX>                                  (362,000) 
<INCOME-CONTINUING>                         (1,569,619)
<DISCONTINUED>                                  49,865
<EXTRAORDINARY>                                      0      
<CHANGES>                                            0 
<NET-INCOME>                                (1,619,484) 
<EPS-PRIMARY>                                    (0.39)  
<EPS-DILUTED>                                    (0.39)     

        

</TABLE>
Exhibit 32.2



Certification



Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)



Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Entrust, Inc., a Maryland corporation (the Company), hereby certifies, to such officers knowledge, that:



The Annual Report on Form 10-K for the year ended December 31, 2003 (the
Report) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.





|                        |  |                                                             
|----------------------- |  | ------------------------------------------------------------
|Date:    March 15, 2004 |  | /s/    David J. Wagner                                      
|                        |  | Name:    David J. Wagner Title:      Chief Financial Officer
EXHIBIT 23.1





                         Consent of Independent Auditors



Board of Directors
Global Med Technologies, Inc.:

We consent to  incorporation  by reference in the  Registration  Statements (No.
333-28155, No. 333-39193, No. 333-45031 and No. 333-69851) on Form S-8 of Global
Med  Technologies,  Inc.  and  subsidiary  of our  report  dated  April 9, 1999,
relating to the consolidated balance sheet of Global Med Technologies,  Inc. and
subsidiary as of December 31, 1998, and the related  consolidated  statements of
operations,  stockholders'  equity  (deficit)  and cash  flows for the year then
ended,  which report  appears in the December  31, 1999,  annual  report on Form
10-KSB of Global Med Technologies, Inc. and subsidiary.


                                                          /s/ KPMG LLP
                                                          KPMG LLP



Denver, Colorado
April 27, 2000
# Fourth Court of Appeals **San Antonio, Texas**
MEMORANDUM OPINION
No. 04

- 19

- 00225

- CV
IN RE Abelardo G. GONZALEZ

Original Mandamus Proceeding 1
PER CURIAM Sitting: Sandee Bryan Marion, Chief Justice Rebeca C. Martinez, Justice Liza A. Rodriguez, Justice Delivered and Filed: May 1, 2019
PE T ITION FOR WRIT OF MANDAMUS DENIED AS MOOT In this original proceeding, relator complains the district clerk and court reporter have refused to prepare and file the records in his pending appeal before this court in appellate cause number 04

- 18

- 00833

- CV. On April 17, 2019, in appellate cause number 04

- 18

- 00833

- CV, this
court ordered the clerk’s re cord and reporter’s record filed within thirty days. Because relator has received the relief requested, we d eny his petition for writ of mandamus as moot.
PER CURIAM

1 This proceeding arises out of Cause No. 2017 FLI 001815 C3, styled In the Interest of M.A.G. and Z.A.G., Children , pending in the County Court at Law No

. 2, Webb County, Texas, the Honorable Missy Medary presiding.
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 2114 Introduced in Senate (IS)]

106th CONGRESS
  2d Session
                                S. 2114

 To exempt certain entries of titanium disks from anti-dumping duties 
      retroactively applied by the United States Customs Service.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 29, 2000

   Mr. Wyden introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To exempt certain entries of titanium disks from anti-dumping duties 
      retroactively applied by the United States Customs Service.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TREATMENT OF CERTAIN ENTRIES OF TITANIUM DISKS.

    (a) In General.--Notwithstanding section 514 of the Tariff Act of 
1930 (19 U.S.C. 15144) or any other provision of law, the United States 
Customs Service shall--
            (1) not later than 90 days after the date of the enactment 
        of this Act, liquidate or reliquidate the entries listed in 
        subsection (b) as exempt from antidumping duties under 
        antidumping case number A-462-103; and
            (2) not later than 90 days after such liquidation or 
        reliquidation under paragraph (1), refund any antidumping 
        duties paid with respect to such entries, including interest 
        from the date of entry, if the importer of the entries files a 
        request therefor with the Customs Service within such 90-day 
        period.
    (b) Entries.--The entries referred to in subsection (a) are as 
follows:

 
           Entry Number                         Date of Entry
 
  EE1-0001115-8...................  January 26, 1995
  EE1-0001313-9...................  June 23, 1995
  EE1-0001449-1...................  September 25, 1995
 

                                 <all>
```
FORM 10-Q/A



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549



                   QUARTERLY REPORT UNDER SECTION 13 or 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarter ended September 30, 1998     Commission file number 0-13759
                      ------------------                            -------



                          ANCHOR FINANCIAL CORPORATION
             (Exact name of registrant as specified in its charter)



        South Carolina                                          57-0778015
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                            Identification number)



   2002 Oak St., Myrtle Beach, S. C.                               29577
(Address of principal executive offices)                        (Zip Code)



Registrant's telephone number, including area code  (843) 448-1411


         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934 during the preceding 12 months (or for shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days.

Yes  X     No


         Indicate  the  number of  shares  outstanding  of each of the  issuer's
classes of common stock, as of the latest practicable date.


             Class                             Outstanding at November 10, 1998
 -------------------------------------         --------------------------------
    (Common stock, no par value)                           6,487,148


<PAGE>

                                   SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.




                                          /s/ Stephen L. Chryst
                                          Stephen L. Chryst, President and
                                            Chief Executive Officer



                                          /s/ Tommy E. Looper
                                          Tommy E. Looper, Executive Vice
                                            President and Chief Financial
                                            Officer



                                          /s/ John J. Moran
                                          John J. Moran, Senior Vice President
                                            and Comptroller




Date:  November 10, 1998
[File No. 6966]

#### IN THE MATTER OF THE APPLICATION OF FRED L. ADAMS, GOODRICH, NORTH DAKOTA, for a Special Certificate Authorizing Motor Freight Service in Goodrich and Vicinity in Truckload and Less-than-truckload Lots. NORTHERN PACIFIC RAILWAY COMPANY, a Corporation, Appellant, v. S. S. McDONALD, Ben C. Larkin and C. W. McDonnell, as Members of the Public Service Commission of the State of North Dakota, and Fred L. Adams and Midnite Express, Inc., a Corporation, Respondents.

(21 NW2d 351)

*243Opinion filed August 8, 1945

*Conmy*& *Gonmy,*for appellant.

Mr. *Peter Winter,*for respondent, Adams.

*G. F. Kelsch,*for respondent, Public Service Commission.

Burr, J.

This case is of the same order as the Hanson Case just decided [ante, 224, 21 NW2d 341] and was argued with it. The questions are similar and the issues are the same; the only variation being the territory to he served.

The permit involved allots to the applicant territory lying east of the territory allotted Hanson. The center of operation is Goodrich, some twelve miles east of McClusky and on the same branch line of appellant’s road. The territory to he served comprises seventeen full townships, and thirteen fractions of townships of an area approximating four more townships, all in the eastern part of Sheridan county and the southwestern corner of Wells county. In this territory covered by the permit the towns of Martin, Harvey, and Fessenden on the Soo Railroad, and Bowdon, Chaseley, and Denhoff on the branch line of the Northern Pacific are excluded from service under the permit. The only towns which would be served are Goodrich and Hurdsfield, both on the appellant’s road.

It is conceded that the decision in the Hanson Case determines this one. We find the testimony is similar, the findings of the commission are similar, and the decision of the district court is similar.

The judgment, therefore, is affirmed.

ChristxaNSON, Ch. J., and Nuessle, Burke and Morris, JJ., concur.
Unassociated Document


    [Letterhead
of ComVest Capital, LLC]

    


     

    May 19,
2009

     

    ClearPoint
Business Resources, Inc.

    1600
Manor Drive, Suite 110

    Chalfont,
PA  18914

    


    Re:  Waiver
Letter

     

    Dear
Sirs:

     

    Reference
is made to the Revolving Credit and Term Loan Agreement dated as of June 20,
2008 (the “Agreement”) by and
between ComVest Capital, LLC (the “Lender”) and
ClearPoint Business Resources, Inc. (the “Borrower”).

    


    On the
date hereof, there exist Events of Default under the Agreement consisting of the
failure to pay certain principal installments required under the Term Note
issued pursuant to the Agreement.  The Lender hereby waives such
Events of Default, provided that the
Lender reserves the right to collect, at a later time (but not later than the
maturity date under the Agreement), the increased interest that the Lender was
permitted to charge during the continuance of such Events of
Default.

     

    The
foregoing waiver is effective only in this specific instance, and is not to be
construed as a waiver of (or agreement to waive) any other Event of Default
which may exist or arise.

     

    


    
      	 
      	
              Very
      truly yours,

            	 
      
	 
      	 
      	 
      	 
      
	 
      	
              COMVEST
      CAPITAL, LLC

            	 
      
	 	 	 	 
	 
      	
              By:

            	
              /s/ Robert Capalbo

            	 
      
	 
      	 
      	
              Name:  Robert
      Capalbo

            	 
      
	 
      	 
      	
              Title:  SVP

            	 
      


    

    
       

      Acknowledged,
Confirmed and Agreed To:

    

    


    
      CLEARPOINT
BUSINESS RESOURCES, INC.

    

     

    
      	
              By:

            	
              /s/
      John G. Phillips

            	 
      
	 
      	
              Name:  John
      G. Phillips

            	 
      
	 
      	
              Title:  CFO
exv10w29






Exhibit 10.29




Compensation Arrangements of Certain Executive Officers of Flextronics International Ltd.




Note: The following summary of compensation arrangements does not include all previously-reported
compensation arrangements or awards granted under previously-disclosed incentive plans.
Disclosures with respect to compensation for Named Executive Officers for the 2008 fiscal year are
included in the Company’s definitive proxy statement for the Company’s 2008 Annual General Meeting
of Shareholders, and disclosures with respect to compensation for Named Executive Officers for the
2009 fiscal year will be included in the Company’s definitive proxy statement for the Company’s
2009 Annual General Meeting of Shareholders.



Compensation for Michael McNamara (Chief Executive Officer)




     On June 2, 2008, the Board approved an annual base salary for Mr. McNamara of $1,250,000 for
fiscal year 2009. In addition, Mr. McNamara will participate in the Company’s annual incentive
bonus plan and three-year cash incentive bonus plan.



Compensation for Paul Read (Chief Financial Officer)




     On June 2, 2008, the Board approved an annual base salary for Mr. Read of $600,000 effective
May 15, 2008. In addition, Mr. Read will participate in the Company’s annual incentive bonus plan
and three-year cash incentive bonus plan.



Compensation for Michael J. Clarke




     On April 30, 2008, the Board approved an annual base salary for Mr. Clarke, President of the
Company’s Infrastructure division, of CDN$550,000 for fiscal year 2009. In addition, Mr. Clarke
will participate in the Company’s annual incentive bonus plan and three-year cash incentive bonus
plan.



Compensation for Sean P. Burke




     On April 30, 2008, the Board approved an annual base salary for Mr. Burke, President, of the
Company’s Computing division, of $450,000 for fiscal year 2009. In addition, Mr. Burke will
participate in the Company’s annual incentive bonus plan and three-year cash incentive bonus plan.



Compensation for Carrie Schiff




     On April 30, 2008, the Board approved an annual base salary for Ms. Schiff, Senior Vice
President and General Counsel, of $425,000 for fiscal year 2009. In addition, Ms. Schiff will
participate in the Company’s annual incentive bonus plan and three-year cash incentive bonus plan.